Voima Ventures, a Helsinki and Stockholm-based early-stage investor specializing in science-based startups, has announced the launch of its exciting new
VeriSIM Life eliminates waste and inaccuracy, accelerates preclinical development, and lowers costs and risks when converting drug candidates to clinical trials, and brings life-saving drugs
During a discussion at the Frontiers Health Global Hybrid Conference, panelists said a more competitive funding environment could push startups and investors to focus on quality.
Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence – Padovanews padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.